Buy Protagonist Therapeutics Stock | PTGX Stock Price & Latest News | Public.com
PTGX

Protagonist Therapeutics

$0.00 (0.00%)Today
    View Protagonist Therapeutics (PTGX) stock trends here

    About PTGX

    Protagonist Therapeutics, Inc. engages in the research and development of novel constrained peptide-based drug candidates that address significant unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.2
    -0.39
    -0.59
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.54

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,23B
    Volume381,31k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$31.58
    1 Year Low$5.30
    Open$28.92
    High$29.71
    Low$27.54

    Buy any stock with any amount of money.

    Download the App
    Download the app